This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
ICT Blog RSS
Kelly M. Pyrek

Kelly M. Pyrek has served as editor in chief of Infection Control Today magazine for the past 12 years, and manages a number of ICT-affiliated print and online offerings. Recognized by the Society of Professional Journalists as an award-winning practitioner, she has served as an editorial manager, editor, and writer for newspapers, magazines, wire services and public information bureaus for more than 25 years. She is a graduate of the University of Southern California and is the author of several books on healthcare, forensic science and medico-legal issues.

06/27/2006

Researchers are Rejoicing

Public health research just received an enormous financial shot in the arm with the announcement that Warren Buffett is gifting $31 billion to the Bill & Melinda Gates Foundation to assist the non-profit’s mission to eradicate the most fatal diseases on earth. Among the uses for the money is to develop a vaccine powerful enough to fight AIDS. Gates has said that the journey ahead will be a ...
More  |  Comment(s) 

06/26/2006

An Opportunistic Foe

The New York Times is reporting that an Indonesian who died after catching the A(H5N1) avian influenza virus from his son represents the first confirmed case of human-to-human transmission of the disease. The cluster of outbreaks within the family has been under investigation by the World Health Organization (WHO), whose investigators also discovered that the virus had mutated slightly by the ...
More  |  Comment(s) 

06/23/2006

Don’t Count Your Chickens ...

… before they’re hatched, or in this case, don’t assume that the world was unaffected by avian influenza until last year. The New York Times is reporting today that editors of a prestigious medical journal were asked by a team of authors to withdraw from publication a paper asserting that China’s very first avian flu case appeared in 2003, or just about two years prior to this country ‘fessing up ...
More  |  Comment(s) 

06/22/2006

Dangerous Ink

The MMWR is such an interesting treasure trove of infection-related goodies. This week’s edition is running a fascinating report of CA-MRSA outbreaks among tattoo recipients that were identified by hospital ICPs and reported to local health departments in Ohio, Kentucky, and Vermont from the period of June 2004 through August 2005. As you know, CA-MRSA infections have quickly become a foe to the ...
More  |  Comment(s) 

06/15/2006

You Asked, We Deliver

Many of you read yesterday's blog and announcement on this Web site about the number of lives saved through the Institute for Healthcare Improvement (IHI)'s 100,000 Lives Campaign and wanted to know where you could find a list of all of the U.S. hospitals that particpated. You can access that list of participating hospitals, organized by state, by clicking HERE. For more details about how the ...
More  |  Comment(s) 

06/14/2006

You are a Lifesaver!

Congratulations to the 3,000-plus hospitals across the U.S. that enrolled in the IHI's 100,000 Lives Campaign and endeavored to prevent so many unneccessary deaths relating to infections and other complications. The IHI reports today that approximately 122,000 lives were saved since the advent of the campaign in December 2004. Click HERE for the complete announcement, and HERE for a commentary on ...
More  |  Comment(s) 

06/08/2006

New Support for Short-Course Antibiotic Therapy Emerges

The latest British Medical Journal reports that taking antibiotics for three days is just as effective for community-acquired pneumonia (CAP) as continuing treatment for the recommended seven to 10 days. We know that shorter courses of treatment can aid in the fight against antibiotic resistance, but it raises the question of what, then, is the optimal duration of antibiotic therapy for common ...
More  |  Comment(s)